Dawn Faller/Linkedin
Apr 24, 2026, 17:35
Dawn Faller: Strengthening Global Collaboration in Apheresis at the 2026 ASFA and WAA Joint Meeting
Dawn Faller, Sr. Manager of Global Clinical Marketing at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
”Today we had the opportunity to welcome attendees of the 2026 ASFA and WAA Joint Meeting to the Terumo Blood and Cell Technologies Campus Headquarters ahead of the meeting kickoff.
This tour was a great opportunity to showcase the people and technologies behind our work.
It also highlighted how our teams at Terumo Blood and Cell Technologies are working alongside partners across the field to advance apheresis and help ensure blood remains an essential therapy for patients worldwide.
Looking forward to continuing these conversations throughout the conference.”
Stay updated with Hemostasis Today.
-
Sep 17, 2026, 16:30Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias